Who
Anand Kiran Parikh
President and CEO
Company insider
Files Form 4 as: President and CEO, Faeth Therapeutics.
In numbers
- Trades disclosed
- 30
- Buys
- 1
- Sells
- 0
- Bought
- $111K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 17 Feb 2026
- Last trade
- 21 Jul 2026
- Last filed
- 23 Jul 2026
Companies traded
Activity over time
1 Jun – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 Jul 2026filed 23 Jul 2026 | FTH Faeth Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —398,018 at $0.00 | filing |
| 21 Jul 2026filed 23 Jul 2026 | FTH Faeth Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —398,018 at $0.00 | filing |
| 22 Jun 2026filed 24 Jun 2026 | FTH Faeth TherapeuticsBiotechnology | SEC FORM 4 Bought | $55K2,806 at $19.76 | filing |
| 22 Jun 2026filed 24 Jun 2026 | FTH Faeth TherapeuticsBiotechnology | SEC FORM 4 Code M | $52K45,252 at $1.16 | filing |
| 22 Jun 2026filed 24 Jun 2026 | FTH Faeth TherapeuticsBiotechnology | SEC FORM 4 Code M | $9,5278,213 at $1.16 | filing |
| 22 Jun 2026filed 24 Jun 2026 | FTH Faeth Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —45,252 at $0.00 | filing |
| 22 Jun 2026filed 24 Jun 2026 | FTH Faeth Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —8,213 at $0.00 | filing |
| 22 Jun 2026filed 24 Jun 2026 | FTH Faeth Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —45,252 at $0.00 | filing |
| 22 Jun 2026filed 24 Jun 2026 | FTH Faeth Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —8,213 at $0.00 | filing |
| 22 Jun 2026filed 24 Jun 2026 | FTH Faeth TherapeuticsBiotechnology | SEC FORM 4 Bought | $55K2,806 at $19.76 | filing |
| 22 Jun 2026filed 24 Jun 2026 | FTH Faeth TherapeuticsBiotechnology | SEC FORM 4 Code M | $52K45,252 at $1.16 | filing |
| 22 Jun 2026filed 24 Jun 2026 | FTH Faeth TherapeuticsBiotechnology | SEC FORM 4 Code M | $9,5278,213 at $1.16 | filing |
| 15 Jun 2026filed 16 Jun 2026 | FTH Faeth TherapeuticsBiotechnology | SEC FORM 4 Code C | —761,428 | filing |
| 15 Jun 2026filed 16 Jun 2026 | FTH Faeth Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —761.428 | filing |
| 15 Jun 2026filed 16 Jun 2026 | FTH Faeth Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —761.43 | filing |
| 15 Jun 2026filed 16 Jun 2026 | FTH Faeth TherapeuticsBiotechnology | SEC FORM 4 Code C | —761,428 | filing |
| 19 Feb 2026filed 19 Feb 2026 | FTH Faeth Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,239,305 at $0.00 | filing |
| 19 Feb 2026filed 19 Feb 2026 | Sensei Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,239,305 at $0.00 | filing |
| 17 Feb 2026filed 16 Jun 2026 | FTH Faeth Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —761.428 | filing |
| 17 Feb 2026filed 16 Jun 2026 | FTH Faeth Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,320 | filing |
News
Sensei Biotherapeutics (NASDAQ:FTH) Shares Down 7% – Should You Sell?FTH · dailypolitical.com · 13 Oct 2026FinancialContent - Faeth Therapeutics, Inc. - Common Stock (Nasdaq:FTH) Stock QuoteFTH · financialcontent.com · 7 Oct 2026
0 headlines in the last 90 days name Anand Kiran Parikh; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.